Lambda snags Biovail's Toronto CRO

India's Lambda Therapeutic Research has acquired Biovail's Canadian CRO and renamed it Lambda Canada. The 46,000-square-foot research center in Toronto houses 194 beds and a Phase I first-in-human operation. Lambda says it wants to burnish its reputation for developers interested in developing new therapies for the U.S. market. Report